Instituto de Reumatología Mendoza

Instituto de Reumatología Mendoza
Ciudad de Mendoza, M5631AHF
Select an option
Our team
Medical staff
Alfredo Luis Borgia
Open studies
Lupus
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-2 - BiogenSee more
Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Alexion PharmaceuticalsSee more
A Study to Assess the Efficacy and Safety of BIIB059 (Litifilimab) in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy - AMETHYST - BiogenSee more
Nephropathy
Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) - Alexion PharmaceuticalsSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy